Related references
Note: Only part of the references are listed.Fidaxomicin Inhibits Spore Production in Clostridium difficile
Farah Babakhani et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
Irina Artsimovitch et al.
CLINICAL INFECTIOUS DISEASES (2012)
Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts
Daniela Heeg et al.
PLOS ONE (2012)
Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains
Janet Y. Nale et al.
PLOS ONE (2012)
The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile
Shonna M. McBride et al.
MICROBIOLOGY-SGM (2011)
Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production
Michelle Merrigan et al.
JOURNAL OF BACTERIOLOGY (2010)
Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile
Jordi M. Lanis et al.
PLOS PATHOGENS (2010)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer
Karl Weiss
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Short- and long-term attributable costs of Clostridium difficile -: Associated disease in nonsurgical inpatients
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2008)
A Mouse Model of Clostridium difficile-Associated Disease
Xinhua Chen et al.
GASTROENTEROLOGY (2008)
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile
Michael Gerber et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: Clinical and economic consequences
Judith A. O'Brien et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Repression of Clostridium difficile toxin gene expression by CodY
Sean S. Dineen et al.
MOLECULAR MICROBIOLOGY (2007)
Emergence and control of fluoroquinolone-resistant, toxin a-negative, toxin B-Positive Clostridium difficile
Denise Drudy et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Clostridium difficile toxoid vaccine in recurrent C-difficile-associated diarrhea
S Sougioultzis et al.
GASTROENTEROLOGY (2005)
Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile
LJ Drummond et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
